1. Home
  2. OSS vs CRBU Comparison

OSS vs CRBU Comparison

Compare OSS & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

N/A

Current Price

$9.10

Market Cap

197.3M

Sector

Technology

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$1.84

Market Cap

203.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSS
CRBU
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
203.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
OSS
CRBU
Price
$9.10
$1.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$10.00
$10.75
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
03-18-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
133.85
3.64
EPS
0.22
N/A
Revenue
$37,027,382.00
N/A
Revenue This Year
$13.57
$1.63
Revenue Next Year
$23.40
$10.93
P/E Ratio
$40.23
N/A
Revenue Growth
34.46
N/A
52 Week Low
$1.85
$0.66
52 Week High
$12.75
$3.53

Technical Indicators

Market Signals
Indicator
OSS
CRBU
Relative Strength Index (RSI) 46.76 49.21
Support Level $7.95 $1.70
Resistance Level $10.74 $2.07
Average True Range (ATR) 0.96 0.12
MACD -0.05 -0.02
Stochastic Oscillator 22.80 42.68

Price Performance

Historical Comparison
OSS
CRBU

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: